Back to search

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: Response, toxicity, and survival depend on disease histology

Data up to Jan 2025

Published1996
Citations111
References55

Total Citations Per Year

Abstract

References (55)

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]

1994 • 6,495 citations

CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,S

1974 • 3,686 citations

National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usage

1982 • 3,027 citations

A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow Transplantation

1992 • 1,179 citations

High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

1987 • 797 citations

Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow Transplant

1993 • 679 citations

Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts [see comments]

1995 • 557 citations

Induction of Immune Responses in Patients with B-Cell Lymphoma against the Surface-Immunoglobulin Idiotype Expressed by Their Tumors

1992 • 551 citations

ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study.

1994 • 423 citations

Immunomodulatory and Antimicrobial Efficacy of Intravenous Immunoglobulin in Bone Marrow Transplantation

1990 • 398 citations

Treatment of Non-Hodgkin's Lymphoma

1993 • 387 citations

Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation

1991 • 366 citations

Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation

1990 • 349 citations

Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity

1994 • 334 citations

Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's Lymphoma

1992 • 331 citations

Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity

1994 • 294 citations

Allogeneic bone marrow transplantation for low-grade lymphoma.

1998 • 275 citations

Prolonged Disease-Free Survival after Autologous Bone Marrow Transplantation in Patients with Non-Hodgkin's Lymphoma with a Poor Prognosis

1987 • 273 citations

Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.

1987 • 245 citations

Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma.

1994 • 244 citations

Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma

1994 • 233 citations

High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.

1993 • 227 citations

Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data.

1992 • 199 citations

Interferon Alfa Combined with Cytotoxic Chemotherapy for Patients with Non-Hodgkin's Lymphoma

1992 • 176 citations

Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle.

1990 • 174 citations

Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma

1991 • 169 citations

One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome.

1993 • 153 citations

Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management.

1995 • 113 citations

Intermediate lymphocytic lymphoma: clinical and pathologic features of a recently characterized subtype of non-Hodgkin's lymphoma.

1993 • 99 citations

The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantation

1990 • 90 citations

The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomas.

1990 • 82 citations

Fractionated total body irradiation and high-dose VP 16-213 followed by allogeneic bone marrow transplantation in advanced leukemias

1988 • 76 citations

A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: methotrexate/prednisone v cyclosporine A/prednisone.

1987 • 76 citations

High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for Bone Marrow Transplantation.

1994 • 75 citations

Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide.

1993 • 66 citations

CHOP-Bleo plus interferon for stage IV low-grade lymphoma

1993 • 63 citations

High-dose chemotherapy, fractionated total-body irradiation, and allogeneic marrow transplantation for malignant lymphoma.

1986 • 60 citations

High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity.

1995 • 55 citations

Clinical studies of ABMT in non-Hodgkin's lymphoma

1986 • 43 citations

Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies.

1994 • 41 citations

A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic marrow transplantation.

1994 • 40 citations

Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors.

1991 • 39 citations

Allogeneic bone marrow transplantation in adults with Burkitt's lymphoma or acute lymphoblastic leukemia in first complete remission.

1990 • 34 citations

High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma.

1989 • 34 citations

Expression and function of adhesion receptors on normal B cells and B cell non-Hodgkin's lymphomas.

1993 • 31 citations

Burkitt's lymphoma in adults: a retrospective study of 46 cases.

1992 • 30 citations

Treatment of non-Hodgkin's lymphoma with chemoradiotherapy and allogenic marrow transplantation

1983 • 28 citations

Allogeneic marrow transplantation in non-Hodgkin's lymphoma.

1990 • 24 citations

High-dose melphalan and total body irradiation with bone marrow transplantation for refractory malignancies

1986 • 20 citations

High-dose melphalan allows durable engraftment of allogeneic bone marrow.

1995 • 17 citations

Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation.

1989 • 16 citations

Marrow transplantation for non-Hodgkin's lymphoma: a multi-centre study from the European Co-operative Bone Marrow Transplant Group.

1986 • 15 citations

Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiation

1994 • 6 citations

Cited By (0)

Loading...
Allogeneic bone marrow transplantation for poor-prognosis lymphoma: Response, toxicity,… (1996) – The American Journal of Medicine | Metascience Observatory Explorer